MedTrace Logo

Hereditary Influences on Pulmonary Fibrosis Trajectories

NCT07580053 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2026-05-12

No results posted yet for this study

Summary

The SHIFT (Hereditary Influences on Pulmonary Fibrosis Trajectories) study is a prospective, multicenter, observational cohort study designed to investigate familial pulmonary fibrosis (FPF) within the Italian population.

Conditions

  • Interstitial Lung Disease Due to Systemic Disease (Telomere Biology Disorder)
  • Idiopathic Pulmonary Fibrosis (IPF)
  • Telomere Disease
  • Progressive Pulmonary Fibrosis
  • Familial Pulmonary Fibrosis

Sponsors & Collaborators

  • University of Siena

    collaborator OTHER

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    collaborator OTHER

  • Ospedale San Paolo

    collaborator OTHER

  • Istituto Clinico Humanitas

    lead OTHER

Principal Investigators

  • Francesco Amati, MD · Humanitas Research Hospital IRCCS, Rozzano-Milan

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-01
Primary Completion
2034-12-31
Completion
2034-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07580053 on ClinicalTrials.gov